4D Pharma PLC FRPRF:OTCPK

RT Quote | Exchange | USD
Last | 02/26/21 EST
1.96UNCH (UNCH)
52 week range
0.68 - 2.30

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.96
  • 52 Week High2.30
  • 52 Week High Date02/19/21
  • 52 Week Low0.68
  • 52 Week Low Date07/28/20
  • Market Cap249.57M
  • Shares Out131.39M
  • 10 Day Average Volume5,205.27
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.40
  • P/E (TTM)-4.86
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest 4D Pharma PLC News

There is no recent news for this security.

Latest FRPRF News From Our Partners

February 16, 2021

QUOTE FINDER

Profile

MORE
4D pharma plc (4D), formerly Schosween 18 Limited, is a United Kingdom-based pharmaceutical company focusing on developing various projects targeting new therapeutic areas. The principal activity of the Company is research and development of pharmaceutical products in new live biotherapeutic areas. The Company has developed its research to build MicroRx, which is a discovery methodology that is able to rationally select those bacteria that have a precise and evolved...
Axel Glasmacher M.D.
Non-Executive Chairman
Duncan Peyton
Chief Executive Officer
Address
9 Bond Court
Leeds
LS1 2JZ
United Kingdom